Health
Why Some Kentuckians Refuse a Treatment That Could Save Their Lives

Health Points
- Medication-assisted treatment for opioid addiction can be accessed remotely via telehealth in Kentucky
- Persistent misconceptions about Suboxone and virtual care prevent many from seeking help
- Understanding the facts about modern addiction treatment could save lives in communities hit hardest by the opioid crisis
Across Kentucky, a proven treatment for opioid addiction sits within reach — yet many who need it most won’t pick up the phone. The barrier isn’t distance, cost, or availability. It’s something more stubborn: what people believe they already know.
Medication-assisted treatment, or MAT, combines FDA-approved medications like Suboxone with counseling and behavioral therapies to treat opioid use disorder. Studies show it reduces overdose deaths, helps people stay in recovery, and improves quality of life. And in recent years, telehealth has made it possible to start treatment from home, eliminating the need to travel to distant clinics or take time off work.
But old narratives die hard. Some view Suboxone as “just trading one addiction for another,” a phrase that persists in waiting rooms, church basements, and family kitchens across the Commonwealth. Others question whether virtual appointments can provide the same level of care as in-person visits, or worry about privacy when discussing deeply personal struggles over a screen.
These concerns, while understandable, don’t align with the evidence. Suboxone works by blocking the euphoric effects of opioids while easing withdrawal symptoms, allowing the brain to heal without triggering cravings. It’s not a substitute addiction — it’s a medical tool, prescribed and monitored by licensed providers. Telehealth, meanwhile, has been shown to be just as effective as traditional office visits for MAT, with the added benefit of reducing stigma and increasing access for people in rural areas.
Kentucky has been hit harder by the opioid epidemic than most states. In 2023, overdose deaths remained stubbornly high, even as other states saw declines. The need for accessible, evidence-based treatment has never been greater. Yet myths continue to shape decisions — sometimes with fatal consequences.
Health experts say the solution starts with conversation. Talking openly about what MAT is, how it works, and who it helps can begin to chip away at the misinformation that keeps people from seeking care. For Kentuckians ready to take that step, remote treatment offers a path forward that’s private, flexible, and grounded in science.
The question isn’t whether the help is there. It’s whether outdated beliefs will continue to stand in the way.